Liquid cancer treatment could spare patients surgery
Disease control
Recruiting now
This study is testing whether a liquid medication called UGN-104 can effectively treat low-grade cancer in the upper part of the urinary system (kidneys and ureters). About 70 patients will receive the treatment, which is delivered directly to the cancer site through a catheter o…
Phase: PHASE3 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC